Tackling COVID-19
As we stay apart, pharmaceutical companies are coming together to fight against COVID-19
LEARN MORELatest Updates
VIEW ALL-
Blog articles 16.07.21
Beyond the Basics: Tackling post-Covid healthcare challenges in Central and Eastern Europe (Guest blog)...
We need to start to reimagine our healthcare systems. We cannot afford to go back to where we were before. Now is the time for under-resourced and often,...
Read Article -
Statements & press releases 14.07.21
Health Systems after COVID-19 – charting a course for a healthier Europe
EFPIA believes that once we emerge from this crisis, we should not only rebuild our economies and get our societies back on their feet, but also take the...
Read Article -
Blog articles 14.07.21
Nobody Left Outside (Guest blog)
Through advocacy and policy briefs, the NLO coalition has been instrumental in raising awareness of the challenges faced by underserved and stigmatized...
Read Article -
External Events 07.09.21
DIA Pharmacovigilance Strategies Workshop
A unique opportunity to engage in the sharing of good practices between industry representatives and seek the advice you need from regulators.
View Event -
EFPIA Events 24.09.21
Health Systems after COVID-19 - how can the industry contribute to strengthened resilience?
In the effort to making health systems more resilient to future pandemics and other shocks, both public institutions and private stakeholders have an important...
View Event -
EFPIA Events 04.10.21
How can we close the East-West healthcare investment gap in Europe?
Public healthcare spending in CEE countries has grown over time, but at a slower pace than GDP growth and today the average public spending per capita...
View Event
Featured Articles
Featured event
Accelerating Adoption of Complex Clinical Trials in Europe and beyond
A multi-stakeholder workshop to develop shared solutions for the use of complex clinical trials to optimise drug development in Europe
View Event